Format

Send to

Choose Destination
See comment in PubMed Commons below
Dtsch Arztebl Int. 2011 May;108(18):313-9. doi: 10.3238/arztebl.2011.0313. Epub 2011 May 6.

Barrett's adenocarcinoma of the esophagus: better outcomes through new methods of diagnosis and treatment.

Author information

1
Dr. Horst-Schmidt-Kliniken Wiesbaden, Innere Medizin und Klinik Allgemein- und Viszeralchirurgie.

Abstract

BACKGROUND:

Esophageal adenocarcinoma has attracted more attention among gastroenterologists recently because of its rapidly rising incidence in Western countries. Many new epidemiological findings have been published, and there have been numerous technical advances in diagnostic procedures and in multimodal treatment based on the staging of the disease.

METHODS:

In this paper, we selectively review the literature on esophageal adenocarcinoma, also considering the evidence-based recommendations contained in the guidelines of the German Society for Digestive and Metabolic Diseases (Deutsche Gesellschaft für Verdauungs- und Stoffwechselkrankheiten, DGVS) as well as the latest data from our own research team.

RESULTS AND CONCLUSION:

here have been major recent advances in the diagnosis and treatment of esophageal adenocarcinoma. New refinements in endoscopic techniques now make endoscopic treatment possible for early esophageal carcinoma. New surgical techniques and new strategies of neoadjuvant chemotherapy have lowered the morbidity and improved the outcome of patients with locally advanced disease. Molecular therapies, too, have shown promising initial results.

PMID:
21629515
PMCID:
PMC3103982
DOI:
10.3238/arztebl.2011.0313
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Deutsches Aerzteblatt International Icon for PubMed Central
    Loading ...
    Support Center